Logo image of S92.DE

SMA SOLAR TECHNOLOGY AG (S92.DE) Stock Fundamental Analysis

FRA:S92 - Deutsche Boerse Ag - DE000A0DJ6J9 - Common Stock - Currency: EUR

20.16  -0.66 (-3.17%)

Fundamental Rating

2

Overall S92 gets a fundamental rating of 2 out of 10. We evaluated S92 against 53 industry peers in the Semiconductors & Semiconductor Equipment industry. S92 may be in some trouble as it scores bad on both profitability and health. S92 is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year S92 has reported negative net income.
S92 had a negative operating cash flow in the past year.
In multiple years S92 reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: S92 reported negative operating cash flow in multiple years.
S92.DE Yearly Net Income VS EBIT VS OCF VS FCFS92.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.64%, S92 is doing worse than 88.68% of the companies in the same industry.
With a Return On Equity value of -21.28%, S92 is not doing good in the industry: 92.45% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.64%
ROE -21.28%
ROIC N/A
ROA(3y)3.77%
ROA(5y)2.36%
ROE(3y)7.88%
ROE(5y)4.87%
ROIC(3y)N/A
ROIC(5y)N/A
S92.DE Yearly ROA, ROE, ROICS92.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Gross Margin, with a value of 16.52%, S92 is doing worse than 98.11% of the companies in the same industry.
In the last couple of years the Gross Margin of S92 has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for S92 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.32%
GM growth 5Y-0.14%
S92.DE Yearly Profit, Operating, Gross MarginsS92.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

S92 does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, S92 has about the same amount of shares outstanding.
The number of shares outstanding for S92 remains at a similar level compared to 5 years ago.
S92 has a worse debt/assets ratio than last year.
S92.DE Yearly Shares OutstandingS92.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
S92.DE Yearly Total Debt VS Total AssetsS92.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

S92 has an Altman-Z score of 1.82. This is not the best score and indicates that S92 is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.82, S92 is not doing good in the industry: 81.13% of the companies in the same industry are doing better.
S92 has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
S92's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. S92 outperforms 79.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACCN/A
WACC10.12%
S92.DE Yearly LT Debt VS Equity VS FCFS92.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.52 indicates that S92 should not have too much problems paying its short term obligations.
S92 has a worse Current ratio (1.52) than 73.58% of its industry peers.
A Quick Ratio of 0.71 indicates that S92 may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.71, S92 is doing worse than 88.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.71
S92.DE Yearly Current Assets VS Current LiabilitesS92.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for S92 have decreased strongly by -152.15% in the last year.
S92 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -45.93%.
Measured over the past years, S92 shows a quite strong growth in Revenue. The Revenue has been growing by 10.83% on average per year.
EPS 1Y (TTM)-152.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-437.69%
Revenue 1Y (TTM)-45.93%
Revenue growth 3Y15.87%
Revenue growth 5Y10.83%
Sales Q2Q%-17.01%

3.2 Future

The Earnings Per Share is expected to grow by 38.74% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.14% on average over the next years.
EPS Next Y119.37%
EPS Next 2Y59.13%
EPS Next 3Y38.74%
EPS Next 5YN/A
Revenue Next Year1.77%
Revenue Next 2Y2.66%
Revenue Next 3Y3.14%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
S92.DE Yearly Revenue VS EstimatesS92.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
S92.DE Yearly EPS VS EstimatesS92.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for S92. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 30.71 indicates a quite expensive valuation of S92.
Compared to the rest of the industry, the Price/Forward Earnings ratio of S92 indicates a slightly more expensive valuation: S92 is more expensive than 79.25% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 37.13. S92 is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 30.71
S92.DE Price Earnings VS Forward Price EarningsS92.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
S92.DE Per share dataS92.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as S92's earnings are expected to grow with 38.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.13%
EPS Next 3Y38.74%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for S92!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SMA SOLAR TECHNOLOGY AG

FRA:S92 (7/31/2025, 5:29:48 PM)

20.16

-0.66 (-3.17%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners23.68%
Inst Owner ChangeN/A
Ins Owners21.32%
Ins Owner ChangeN/A
Market Cap699.55M
Analysts49.23
Price Target17.92 (-11.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.5
Dividend Growth(5Y)28.99%
DP-14.74%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.93%
Min EPS beat(2)1.06%
Max EPS beat(2)34.8%
EPS beat(4)3
Avg EPS beat(4)25.11%
Min EPS beat(4)-28.28%
Max EPS beat(4)92.88%
EPS beat(8)5
Avg EPS beat(8)15.92%
EPS beat(12)8
Avg EPS beat(12)65.01%
EPS beat(16)11
Avg EPS beat(16)68.42%
Revenue beat(2)1
Avg Revenue beat(2)-6.09%
Min Revenue beat(2)-14.13%
Max Revenue beat(2)1.96%
Revenue beat(4)2
Avg Revenue beat(4)-5.94%
Min Revenue beat(4)-15.17%
Max Revenue beat(4)3.57%
Revenue beat(8)5
Avg Revenue beat(8)-1.46%
Revenue beat(12)7
Avg Revenue beat(12)13.34%
Revenue beat(16)8
Avg Revenue beat(16)15.29%
PT rev (1m)0%
PT rev (3m)6.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 30.71
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B 1.26
P/tB 1.62
EV/EBITDA N/A
EPS(TTM)-3.39
EYN/A
EPS(NY)0.66
Fwd EY3.26%
FCF(TTM)-5.84
FCFYN/A
OCF(TTM)-3.25
OCFYN/A
SpS44.09
BVpS15.95
TBVpS12.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.64%
ROE -21.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.52%
FCFM N/A
ROA(3y)3.77%
ROA(5y)2.36%
ROE(3y)7.88%
ROE(5y)4.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.32%
GM growth 5Y-0.14%
F-Score1
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 116.67%
Cap/Sales 5.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 0.71
Altman-Z 1.82
F-Score1
WACC10.12%
ROIC/WACCN/A
Cap/Depr(3y)160.77%
Cap/Depr(5y)137.06%
Cap/Sales(3y)5.37%
Cap/Sales(5y)4.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-152.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-437.69%
EPS Next Y119.37%
EPS Next 2Y59.13%
EPS Next 3Y38.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-45.93%
Revenue growth 3Y15.87%
Revenue growth 5Y10.83%
Sales Q2Q%-17.01%
Revenue Next Year1.77%
Revenue Next 2Y2.66%
Revenue Next 3Y3.14%
Revenue Next 5YN/A
EBIT growth 1Y-129.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year195.9%
EBIT Next 3Y56.74%
EBIT Next 5YN/A
FCF growth 1Y-459.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-180.09%
OCF growth 3YN/A
OCF growth 5YN/A